PREMIUM By Guy Rogers - 06 March 2021
In a major shot in the arm for Nelson Mandela Bay and SA, a new Covid-19 vaccine is being developed right here on home soil.
Shantivax was designed by Gqeberha-born and raised immunologist Kamsellin Chetty’s company GENLAB, and is being developed in partnership with overseas experts.
This article is reserved for HeraldLIVE subscribers. A subscription gives you full digital access to all our content. Already subscribed? Simply sign in below. Already registered on DispatchLIVE, BusinessLIVE, TimesLIVE or SowetanLIVE? Sign in with the same details.
The ânext generationâ vaccines are being developed in SA
By Nathan Craig
Share
Durban - Two Covid-19 vaccines were being refined in the country with the potential to outsmart current and future variants â strengthening the fight against the pandemic.
Shantivax and had5, were considered to be the next-generation Covid-19 vaccines.
GENLAB, a Gqeberha (formerly Port Elizabeth) based immunotherapy company, and Danish biotechnology company, Immunitrack, were behind Shantivax â the first Covid-19 vaccine of African origin.
The had5 Covid-19 vaccine was designed by Immunitybio Inc, an immunotherapy company from California with a lineage in cancer treatments, along with researchers from the University of Cape Town.
What we know about Shantivax -Africa s first vaccine prototype iol.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iol.co.za Daily Mail and Mail on Sunday newspapers.